Search Media Items

A fact sheet that reviews research about the possibility of a connection between personal hair dye use and cancer.

Hairy cell leukemia treatment options include watchful waiting when there are no symptoms, chemotherapy, biologic therapy, surgery, and targeted therapy. Learn more about the diagnosis and treatment of newly diagnosed and recurrent hairy cell leukemia in this expert-reviewed summary.

Chronic myelogenous leukemia treatment may include targeted therapy, chemotherapy, stem cell transplant, donor lymphocyte infusion, and/or surgery. Learn more about the diagnosis and treatment of CML in this expert-reviewed summary.

Chronic lymphocytic leukemia (CLL) treatment can include observation, steroids, radiation therapy, chemotherapy, surgery, or targeted therapy. Learn more about the diagnosis, prognosis, and treatment of newly diagnosed or recurrent CLL in this expert-reviewed information summary.

Childhood acute lymphoblastic leukemia (ALL) treatment is usually chemotherapy given in phases and determined by risk group. Radiation therapy, targeted therapy and stem cell transplant are sometimes used. Learn more about newly diagnosed and recurrent ALL in this expert reviewed summary.

Treatment options for adult acute myeloid leukemia (AML) include chemotherapy, radiation therapy, stem cell transplant, and other medications. Get detailed information about the treatment of new and recurrent AML in this expert-reviewed summary.

Adult acute lymphoblastic leukemia (ALL) treatment options include chemotherapy, radiation therapy, stem cell transplant, and/or targeted therapy. Get detailed information about newly diagnosed and recurrent ALL in this expert-reviewed summary.

Hairy cell leukemia treatment options include surveillance, chemotherapy, targeted therapy/immunotherapy, and splenectomy. The decision to treat is based on cytopenias, splenomegaly, or infectious complications. Get detailed information about hairy cell leukemia in this clinician summary.

For acute lymphoblastic leukemia (ALL), the 5-year survival rate has improved significantly since 1975. Get information about risk factors, signs, diagnosis, molecular features, survival, risk-based treatment assignment, and induction and postinduction therapy for children and adolescents with newly diagnosed and recurrent ALL.

Chronic myelogenous leukemia treatments include tyrosine kinase inhibitors, high-dose therapy with allogeneic transplantation, and other medications. Get detailed information about chronic myelogenous leukemia (CML) treatment options in this summary for clinicians.